Objective: To compare the ratios of requests of aspartate aminotransferase (AST) to alanine aminotransferase (ALT) and urea to creatinine (Crea); to investigate the variability among regions and to calculate the potential savings if a target is reached.
Those are meaningful in benchmark studies when used in the emergency room, or in primary care in public health systems. 5, 6 Other indicators such as the ratio of request of related tests have a supplemental role when monitoring strategies over time, once interventions have been implemented. These indicators are very useful since they can be used independently of the health care model, in private or public models, as they do not rely on a catchment area or covered population. The use of indicators based on request ratios avoids a number of potential problems related to the size of the population served. Additionally, they could have a recognized target that could suggest an appropriate test request when achieved. Larsson et al 8 recommended
only serum alanine aminotransferase (ALT) and alkaline phosphatase as liver markers in primary care, and also recommended to reduce the ratio of request of aspartate aminotransferase (AST) to ALT (AST:ALT) to 0.25. In the same way, serum urea adds little information when ordered in combination with serum creatinine for most patients. It should thus be possible to reduce the urea to creatinine ra-tio (Urea:Crea) to less than 0.1. In all, these indicators can be used to compare or to monitor the demand of laboratory tests over time in different settings such as the hospital, 8 primary care 6, 9 or even the emergency room. 5 The AST:ALT and Urea:Crea have been used for that purpose in Spanish Redconlab studies, and so far the recommended goals 10 have not been achieved. The aim of this study was to analyze the results of the AST:ALT and Urea:Crea indicators in primary care in a large population in Spain, to compare the differences in such ratios among different regions, and to calculate the potential savings if the recommended target is achieved.
Materials and Methods

Setting
Every Spanish citizen possesses the Individual Health Care Card, which grants access public health services throughout the Spanish National Health System. Spain is divided into 17 regions called autonomous communities (AACCs) that are themselves divided into Health Departments (HDs). Each HD covers a geographic area and its population, and is composed of several primary care centers and usually a unique hospital. The clinical laboratory is located in this hospital and serves the needs of every HD inhabitant.
Data Collection
A cross-sectional study was designed and conducted at a core laboratory. A call for data was posted via email. Spanish laboratories were invited to fill out an enrollment form and submit their results online. The questionnaire was also disseminated to the participants of previous Redconlab studies that recommended other laboratories to join the current edition and through a group on LinkedIn (https:// www.linkedin.com/in/redconlab-grupo-a5663bb7). Each participating laboratory was required to obtain the request for AST, ALT, creatinine, and urea from primary care in the year 2014 from its local laboratory information system, and to provide organizational data. Each participant was also asked via email for the reagent price of urea and AST to calculate the average test's reagent cost and potential savings.
Data Processing
After collecting the data, we calculated the ratios of AST:ALT and Urea:Crea in every HD. Taking into account the reagent cost, we calculated the potential economic savings if each HD achieved the indicator target (0.25 for AST:ALT, and 0.1 for Urea:Crea). AACC when there were more than 4 participants, and an additional group was created, joining the results of the rest. AACCs were coded by numbers for confidentiality. Every indicator result was compared among the different AACCs.
Statistical Analysis
All analyses were performed using SPSS for Windows, Version 21.0. (SPSS, Chicago, IL). Descriptive statistics were generated for both indicators. The differences in the indicators among AACCs were calculated by way of the Kruskal-Wallis test analysis. A 2-sided P ≤ .05 rule was utilized as the criterion for rejecting the null hypothesis of no difference.
Results
Participating in the study were 110 laboratories from 15 AACCs throughout Spain, representing a catchment area of 27,798,262 inhabitants (59.8% of the Spanish population).
In total, 6,376,293; 9,199,401; 9,993,971; and 5,345,957 AST, ALT, creatinine, and urea, respectively, were requested from primary care during 2014. The figures would have been 10,586,940; 15,274,320; 16,593,590; and 8,876,213, respectively, if extrapolated to the entire Spanish population (46,155,123 inhabitants). Figure 1 shows both indicator results in each HD, compared with the indicator target; 21 laboratories reached the goal in AST:ALT ( Figure 1A ) and 6 in Urea:Crea ( Figure 1B) . As shown, 2 HDs had a higher request for AST than for ALT, and in 44% of the HDs, the ratio was above 0.9.
Sixty laboratories reported the price of the reagent. Ten groups of AACCs had more than 4 participants (in alphabetical order: Andalucía, Canarias, Castilla La Mancha, Castilla Leon, Extremadura, Galicia, Madrid, Murcia, País Vasco and Valencia) and an eleventh group, comprising AACCs did not reach the 4 participants (in alphabetical order: Aragon, Asturias, Baleares, Cantabria, and Cataluña). A statistically significant difference among AACCs was found in the Urea:Crea ratio (P = .049); however, no difference was found in AST:ALT (P = .47). Table 1 shows the value of the indicators in each AACC and also the potential savings if both indicators reach the indicator target. Figure 2 shows the distribution of AST:ALT ( Figure 2A) and Urea:Crea ( Figure 2B ) in the different AACCs.
Discussion
A significant variability was found in the ratios of request of related tests among Spanish HDs. Urea:Crea indicator result was different among AACCs, and most laboratories did not reach both indicator goals, only 21 for AST:ALT and 6 for Urea:Creatinine, although not a single AACC reached both indicator targets. If such tests would have been requested according to accepted standard metrics, more than US$2 million could have been saved when extrapolating to the entire Spanish population.
Such variability among HDs is difficult to explain based on different patients' case mixes in primary care. Our results suggest that different customs or habits among regions could be behind such dissimilarities in tests request. However, only Urea:Crea results were different among regions, despite the values observed in AST:ALT. It is difficult to know why regional practice variation was more obvious for Urea:Crea than for AST:ALT. The fact that an AST overrequest was identified and communicated in prior REDCONLAB studies might be in part responsible for this.
In any case, still AST was more often requested than ALT in 2 HDs, despite ALT's higher specificity for liver disease diagnosis, and the limited use of pairs of ALT and AST whose results are highly correlated.
11
The potential savings, if extrapolating the entire Spanish population, are high. In fact other authors estimate that US$100 million could be saved annually in the US health care budget by selectively limiting AST testing in just the US outpatient environment. 11 The high potential savings highlight the concept of "little ticket test"; each of the tests studied is very cheap, but generates large expenses for the health care system because they are highly requested.
12 Additionally, our study shows that test requests can be monitored through laboratory appropriateness indicators as the ratio of request of related tests. In fact, ratio of request of related tests is a useful tool to determine if redundant tests are requested more often in a particular setting, as compared to standard metrics. The origin of the specified ratio of test ordering for AST:ALT and Urea:Crea (0.25 AST:ALT, 0.1 Urea:Crea) is that the AST:ALT combination is usually ordered as a marker for liver damage, but in most cases, ALT alone would be sufficient, as it is more liver-specific than AST. Serum urea adds little information when ordered in combination with serum creatinine. 8 Those metrics have already proven useful in primary care 6, 9 and emergency room in Spain. 5 The current study also highlights that we still do not comply with request recommendations in the majority of HDs, and that there are differences in Urea:Creatinine among Spanish AACCs. The awareness of such variability will hopefully result in the design and implementation of strategies in the AACCs that could also be monitored through these indicators, with subsequent reduction in expenses.
The study had certain limitations. The financial analysis only included the reagent cost; if the expenses in laboratory personnel and hardware would have been taken into account, the expenses would have been higher. Additionally, the calculated economic savings may not apply to other countries, since Spain has a public health network, with low reagent prices. Moreover we do not know if the differences in both indicator results could be partly explained by different request forms, electronic requesting systems, panels, profiles, or algorithms because we lack that information. Finally, we did not consider the study of other requests ratios such as amylase:lipase, and there might be a lack of justification for the targets and insufficient evidence that the indicators targets are clinically appropriate, as they were given as hypothetical indicators values to indicate potential savings.
There was a significant variability in the request ratios AST:ALT and Urea:Crea, and differences in Urea:Crea indicator values among Spanish AACCs, and a significant unnecessary financial burden that suggest the need to promote the optimal requesting rate through corrective interventions agreed upon laboratory professionals and clinicians. LM
